1. Home
  2. BTBD vs PRPO Comparison

BTBD vs PRPO Comparison

Compare BTBD & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BT Brands Inc.

BTBD

BT Brands Inc.

N/A

Current Price

$1.78

Market Cap

7.1M

ML Signal

N/A

Logo Precipio Inc.

PRPO

Precipio Inc.

N/A

Current Price

$27.50

Market Cap

42.0M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
BTBD
PRPO
Founded
1987
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.1M
42.0M
IPO Year
2019
2000

Fundamental Metrics

Financial Performance
Metric
BTBD
PRPO
Price
$1.78
$27.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
35.6K
137.5K
Earning Date
05-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
92.15
EPS
N/A
N/A
Revenue
$14,823,472.00
$24,049,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
29.77
52 Week Low
$1.03
$16.01
52 Week High
$2.48
$33.63

Technical Indicators

Market Signals
Indicator
BTBD
PRPO
Relative Strength Index (RSI) 69.65 51.73
Support Level $1.10 $25.46
Resistance Level $1.93 $29.20
Average True Range (ATR) 0.13 1.90
MACD 0.02 -0.29
Stochastic Oscillator 80.33 31.15

Price Performance

Historical Comparison
BTBD
PRPO

About BTBD BT Brands Inc.

BT Brands Inc operates and owns a fast-food restaurant called Burger Time. Its offerings include a variety of burgers and other affordable items, including sides and soft drinks. The company owns and operates Keegan's Seafood Grille (Keegan's), a dine-in restaurant located in Florida; Pie In The Sky Coffee and Bakery (PIE), located in Massachusetts; and Schnitzel Haus, a German-themed restaurant located in Florida. The company's revenues are derived from the sale of food and beverages at its restaurants.

About PRPO Precipio Inc.

Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

Share on Social Networks: